文献速递免疫规划妇幼与学校卫生

韩国婴儿轮状病毒疫苗接种后肠套叠风险

Intussusception risk after rotavirus vaccination in Korean infants.
PubMed 文献 · Vaccine · 2025-09-23

本研究利用韩国疾病管理厅接种登记与国家健康保险服务理赔数据,对2016年6月1日至2022年12月31日期间接种至少一剂Rotarix或RotaTeq的不足1岁婴儿开展自身对照病例系列研究。结果显示,Rotarix首剂后1-7天肠套叠风险升高(aIRR 3.15,95%CI 1.54-6.44),RotaTeq各风险区间未见显著风险升高。

要点

  • Rotarix首剂后1-7天肠套叠风险升高,aIRR 3.15(95%CI 1.54-6.44)。
  • Rotarix首剂后归因风险为每10万剂2.17(95%CI 1.11-2.68)。
  • RotaTeq各风险区间均未观察到肠套叠风险显著升高。

核心结论

  • Rotarix首剂接种后7天内肠套叠风险升高,而RotaTeq接种后未观察到风险升高的显著证据。

研究设计与样本

  • 自身对照病例系列研究,使用韩国疾病管理厅接种登记与国家健康保险服务理赔数据。
  • 纳入2016年6月1日至2022年12月31日期间出生后8个月内接种至少一剂Rotarix或RotaTeq的不足1岁婴儿。
  • 肠套叠事件定义为首次因肠套叠住院,风险区间为接种后1-7天、8-21天和1-21天,观察期为出生至1岁。
  • 采用条件泊松回归模型估计按月龄间隔调整年龄效应后的调整发病率比(aIRR),并用伪似然方法处理肠套叠后潜在接种禁忌。

主要发现

  • 786,977名接种Rotarix的婴儿中发生764例肠套叠,800,232名接种RotaTeq的婴儿中识别751例肠套叠。
  • Rotarix首剂后1-7天风险区间的IRR为3.15(95%CI 1.54-6.44),归因风险为每10万剂2.17(95%CI 1.11-2.68),绝对风险为每10万剂3.18。
  • RotaTeq在所有风险区间均未观察到肠套叠风险显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: An increased risk of intussusception after Rotavirus vaccination has been reported, with varying levels of risk associated with Rotarix and RotaTeq. This study evaluates the risk of intussusception following Rotarix and RotaTeq vaccination in Korean infants. METHODS: We performed a self-controlled case series study using vaccination registry from the Korea Disease Control and Prevention Agency and the National Health Insurance Service claims data. This study included infants aged less than one year who received at least one dose of Rotarix or RotaTeq within 8 months of birth between June 1, 2016, and December 31, 2022. An intussusception event was defined as the first hospitalization for intussusception. We defined the risk intervals as 1-7 days, 8-21 days, and 1-21 days post-vaccination and the observation period as from birth to one year. Conditional Poisson regression model was used to estimate the adjusted incidence rate ratio (aIRR) with adjustments for age effects by the monthly interval. The attributable risk was calculated using aIRR estimates and the estimated number of vaccine doses administered to the infants. Pseudo-likelihood methods accounted for the potential contraindication to vaccination after intussusception. RESULTS: Among 786,977 infants receiving Rotarix, 764 intussusception cases occurred, while 751 cases were identified among 800,232 infants who received RotaTeq. For Rotarix, the IRR during the 1-7 day risk intervals after the first dose was 3.15 (95 % confidence interval [CI] 1.54-6.44) with an attributable risk of 2.17 (95 % CI 1.11-2.68) per 100,000 doses and an absolute risk of 3.18 per 100,000 doses. No significant increase in intussusception risk was observed for RotaTeq across all risk intervals. CONCLUSIONS: The risk of intussusception increased within 7 days after the first dose of Rotarix vaccination, while no significant evidence of an increased risk was observed after RotaTeq vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cho H, Jeong NY, Kim HJ, et al. Intussusception risk after rotavirus vaccination in Korean infants. Vaccine. 2025. PMID: 40992076. doi:10.1016/j.vaccine.2025.127782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。